GMED
Undervalued by 188.6% based on the discounted cash flow analysis.
Market cap | $8.27 Billion |
---|---|
Enterprise Value | $8.19 Billion |
Dividend Yield | $- (-) |
Earnings per Share | $0.76 |
Beta | 1.2 |
Outstanding Shares | 135,205,000 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 23.23 |
---|---|
PEG | 4.31 |
Price to Sales | 3.17 |
Price to Book Ratio | 1.94 |
Enterprise Value to Revenue | 3.12 |
Enterprise Value to EBIT | 28.04 |
Enterprise Value to Net Income | 22 |
Total Debt to Enterprise | 0.02 |
Debt to Equity | 0.03 |
No data
No data